Medical Watch Digest for Dec. 9 Acute lymphoblastic leukemia highest survival rate among pediatric cancers Survival rates for ...
For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for ...
HealthDay on MSN10d
New Hope Against a Tough-to-Treat Leukemia in AdultsA newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show ...
For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an ...
Just days before his fourth birthday, Santiago was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), the most ...
MedPage Today on MSN7d
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic LeukemiaSAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without ...
Tecartus demonstrated similar effectiveness across age groups of patients with relapsed or refractory B-cell acute ...
Brexucabtagene autoleucel showed comparable efficacy outcomes in patients aged 60 to 69 with relapsed/refractory B-cell acute ...
Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...
Brianna Blank was just three-and-a-half when she was diagnosed with acute lymphoblastic leukemia. She received physically draining treatments for almost two years. "It takes a lot out of you. When you ...
Long-term follow-up showed continued meaningful responses in patients with relapsed or refractory KMT2Ar acute leukemia who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback